Report Overview:
Biodegradable microneedle patches are a revolutionary method for transdermal drug delivery, offering a painless and efficient way to deliver macromolecules, such as drugs and genes, through the skin. Unlike traditional hypodermic needles, these patches use small microneedles that dissolve under the skin, allowing for the gradual release of therapeutic agents. The biodegradable nature of these microneedles ensures that they do not require removal, as they dissolve into the skin, leaving minimal residue. This delivery method is increasingly being utilized for local therapeutic gene delivery, chronic disease treatments, and vaccine administration. The microneedle patches promise several benefits, including enhanced drug efficacy, faster delivery times, and the ability to customize dosages.
Market Value:
The global Biodegradable Microneedle Patch market was valued at approximately USD 142 million in 2024 and is anticipated to expand significantly, reaching USD 217.93 million by 2032. This growth represents a compound annual growth rate (CAGR) of 5.50% during the forecast period from 2025 to 2032. CAGR of 5.50% (2025 – 2032)
By Types:
• Hospital Pharmacy
• Retail Pharmacy
• Online Pharmacy
By Applications: Drugs
Vaccination
Key players include:
• CosMED Pharmaceutical
• StemProtein
• Including or Excluding key companies relevant to your analysis.
